Ophthotech Corporation, is a private company headquartered in Princeton, New Jersey with offices also in New York, New York. By leveraging their experience and expertise in the back of the eye diseases, the company is focused on developing and commercializing therapies for Age-Related Macular Degeneration (AMD) in an accelerated manner.